Use of Mometasone furoate in prolonged treatment of experimental spinal cord injury in mice: A comparative study of three different glucocorticoids

Pharmacological Research

Volumn 99, Issue , 2015, Pages 316-328

  Galuppo, Maria ^a   Rossi, Antonietta ^b   Giacoppo, Sabrina ^a   Pace, Simona ^b   Bramanti, Placido ^a   Sautebin, Lidia ^b   Mazzon, Emanuela ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Apoptosis; Glucocorticoids; Inflammation; Mometasone furoatea; Oxidative stress; Spinal cord injury

Indexed keywords

DEXAMETHASONE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; METHYLPREDNISOLONE SODIUM SUCCINATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MOMETASONE FUROATE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; GLUCOCORTICOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; EXPERIMENTAL SPINAL CORD INJURY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LONG TERM CARE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPINAL CORD; ANIMAL; CELL LINE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES;

ANIMALS; APOPTOSIS; CELL LINE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; INFLAMMATION; MALE; MAP KINASE SIGNALING SYSTEM; METHYLPREDNISOLONE HEMISUCCINATE; MICE; MOMETASONE FUROATE; NITRIC OXIDE SYNTHASE TYPE II; POLY(ADP-RIBOSE) POLYMERASES; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84937914531     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.07.013     Document Type: Article

References (38)

1. A. McDonough, A. Monterrubio, J. Ariza, and V. Martinez-Cerdeno Calibrated forceps model of spinal cord compression injury J. Vis. Exp. 2015 10.3791/52318
2. Immobilisation Emerg. Nurse 23 2 2015 17 10.7748/en.23.2.17.s25
3. W.O. McKinley, R.T. Seel, and J.T. Hardman Nontraumatic spinal cord injury: incidence, epidemiology, and functional outcome Arch. Phys. Med. Rehabil. 80 1999 619 623
4. R.M. Shavelle, M.J. Devivo, D.R. Paculdo, L.C. Vogel, and D.J. Strauss Long-term survival after childhood spinal cord injury J. Spinal Cord Med. 30 2007 48 54
5. J.R. Dimar, C. Fisher, A.R. Vaccaro, D.O. Okonkwo, M. Dvorak, M. Fehlings, R. Rampersaud, and L.Y. Carreon Predictors of complications after spinal stabilization of thoracolumbar spine injuries J. Trauma 69 2010 1497 1500
6. T. Haider, R. Hoftberger, B. Ruger, M. Mildner, R. Blumer, A. Mitterbauer, and et al. The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in rats Exp. Neurol. 267 2015 230 242
7. M.G. Fehlings, and D.H. Nguyen Immunoglobulin g: a potential treatment to attenuate neuroinflammation following spinal cord injury J. Clin. Immunol. 30 2010 109 112
8. Y.K. Zhang, J.T. Liu, Z.W. Peng, H. Fan, A.H. Yao, P. Cheng, and et al. Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury J. Neuroinflammation 10 2013 112
9. N. Sundahl, J. Bridelance, C. Libert, K. De Bosscher, and I.M. Beck Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds Pharmacol. Ther. 2015 10.1016/j.pharmthera.2015.05.001
10. J.E. Goodwin, Y. Feng, H. Velazquez, and W.C. Sessa Endothelial glucocorticoid receptor is required for protection against sepsis Proc. Natl. Acad. Sci. U. S. A. 110 2013 306 311
11. E. Zambrano, L.A. Reyes-Castro, and P.W. Nathanielsz Aging, glucocorticoids and developmental programming Age 37 2015 9774
12. P.A. O'Connor, O. McCormack, C. Gavin, R. Dungan, C. Kirke, D. McCormack, and et al. Methylprednisolone in acute spinal cord injuries Ir. J. Med. Sci. 172 2003 24 26
13. W.L. Liu, Y.H. Lee, S.Y. Tsai, C.Y. Hsu, Y.Y. Sun, L.Y. Yang, and et al. Methylprednisolone inhibits the expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycans in reactivated astrocytes Glia 56 2008 1390 1400
14. M.B. Bracken, M.J. Shepard, W.F.T.R. Collins. Holford Jr, D.S. Baskin, H.M. Eisenberg, and et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second national acute spinal cord injury study J. Neurosurg. 76 1992 23 31
15. M.B. Bracken Steroids for acute spinal cord injury Cochrane Database Syst. Rev. 1 2012 CD001046
16. P. Cochrane, W. Masri, and J. Silver The effects of steroids on the incidence of gastrointestinal haemorrhage after spinal cord injury: a case-controlled study Spinal Cord 52 2014 501
17. T. Matsumoto, T. Tamaki, M. Kawakami, M. Yoshida, M. Ando, and H. Yamada Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury Spine 26 2001 426 430
18. S. Soost, M. Abdollahnia, K. Kostev, and M. Worm Topical therapy of hand eczema - analysis of the prescription profile from dermatologists in private practice J. Dtsch. Dermatol. Ges. 10 2012 180 184
19. H.S. Friedman, P. Navaratnam, and J. McLaughlin Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma J. Asthma 47 2010 994 1000
20. M.J. Herold, K.G. McPherson, and H.M. Reichardt Glucocorticoids in t cell apoptosis and function Cell. Mol. Life Sci. 63 2006 60 72
21. A.S. Rivlin, and C.H. Tator Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat Surg. Neurol. 10 1978 38 43
22. M. Galuppo, S. Giacoppo, G.R. De Nicola, R. Iori, E. Mazzon, and P. Bramanti Rs-glucoraphanin bioactivated with myrosinase treatment counteracts proinflammatory cascade and apoptosis associated to spinal cord injury in an experimental mouse model J. Neurol. Sci. 334 2013 88 96
23. A.F. Swindall, J.A. Stanley, and E.S. Yang PARP-1: friend or foe of DNA damage and repair in Tumorigenesis Cancers (Basel) 5 2013 943 958
24. A. Veerakumar, J.J. Cheng, A. Sunshine, X. Ye, R.D. Zorowitz, and W.S. Anderson Baclofen dosage after traumatic spinal cord injury: a multi-decade retrospective analysis Clin. Neurol. Neurosurg. 129 2015 50 56
25. G. Stinco, S. Lautieri, F. Piccirillo, F. Valent, and P. Patrone Response of cutaneous microcirculation to treatment with mometasone furoate in patients with psoriasis Clin. Exp. Dermatol. 34 2009 915 919
26. J. Faergemann, O. Christensen, P. Sjovall, A. Johnsson, K. Hersle, P. Nordin, and et al. An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis J. Eur. Acad. Dermatol. Venereol. 14 2000 393 396
27. W.E. Berger Mometasone furoate/formoterol in the treatment of persistent asthma Expert Rev. Respir. Med. 5 2011 739 746
28. D. Zhao, L. Qian, J. Shen, X. Liu, K. Mei, J. Cen, and et al. Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma J. Cell. Mol. Med. 18 2014 1081 1086
29. J.J. Wu, X.H. Wang, L. Li, X. Li, L. Zhang, Z.C. Sun, and et al. Fotemustine, teniposide and dexamethasone in treating patients with CNS lymphoma Asian Pac. J. Cancer Prev. 15 2014 4733 4738
30. T. Genovese, E. Esposito, E. Mazzon, C. Muia, R. Di Paola, R. Meli, and et al. Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury J. Pharmacol. Exp. Ther. 325 2008 100 114
31. N.R. Bhat, P. Zhang, J.C. Lee, and E.L. Hogan Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures J. Neurosci. 18 1998 1633 1641
32. T. Tikka, B.L. Fiebich, G. Goldsteins, R. Keinanen, and J. Koistinaho Minocycline a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia J. Neurosci. 21 2001 2580 2588
33. S.H. Choi, E.H. Joe, S.U. Kim, and B.K. Jin Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo J. Neurosci. 23 2003 5877 5886
34. C.K. Combs, J.C. Karlo, S.C. Kao, and G.E. Landreth Beta-amyloid stimulation of microglia and monocytes results in tnfalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis J. Neurosci. 21 2001 1179 1188
35. M. Brenner Role of GFAP in cns injuries Neurosci. Lett. 565 2014 7 13
36. S. Brahmachari, Y.K. Fung, and K. Pahan Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide J. Neurosci. 26 2006 4930 4939
37. C. Maier, A. Scheuerle, B. Hauser, H. Schelzig, C. Szabo, P. Radermacher, and et al. The selective poly(adp) ribose-polymerase 1 inhibitor ino1001 reduces spinal cord injury during porcine aortic cross-clamping-induced ischemia/reperfusion injury Intensive Care Med. 33 2007 845 850
38. K.L. Wu, C. Hsu, and J.Y. Chan Nitric oxide and superoxide anion differentially activate poly(adp-ribose) polymerase-1 and bax to induce nuclear translocation of apoptosis-inducing factor and mitochondrial release of cytochrome c after spinal cord injury J. Neurotrauma 26 2009 965 977